“…cis-2-(3-hydroxy-phenyl)-1 -pyrrolidino cyclohexane methobromide (Dettmar, Lewis, Metcalf, Readhead, Smith, Gillett, Hedges & Richens, 1974a;Dettmar, Metcalf, Smith, Gillett, Hedges & Richens, 1974b) was injected into the ventricles, or perfused at selected diencephalic sites, in the conscious cat. This compound is one of a series of anticholinesterases recently developed (Lewis, Readhead, Metcalf, Smith & McNally, 1973) and was considered suitable for the present study because it has been shown to lack direct agonist activity at post-synaptic cholinoceptor sites (C.F.C.…”